Tongue Carcinoma — Trials

Tongue Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

26 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 6
Recruiting: 3
Ph III recruiting: 1
Growth YoY: —
Industry share: 17%
Top sponsor: EvolveImmune United, Inc
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01254617	Lenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck Cancer(ADCC)	completed	Phase 1	24	National Cancer Institute (NCI)NIH	1	Mar 13, 2020	clinicaltrials

Data updated 22 days agoSource updated Mar 13, 2020source: clinicaltrials